"BIOTECHNOS" – innovations in medicine
BIOTECHNOLOGY – a Romanian pharmaceutical company founded in 1993. The main activity is the production of original medicines and active pharmaceutical ingredients.
BIOTECHNOS has its own research base, whose specialists conduct research in the pharmaceutical sector, as well as in related industries: biotechnology, cellular and molecular biology, dermatocosmetics and the food industry. For the past ten years, BIOTECHNOS has annually participated in the National Research Program of Romania and actively cooperates with European and international companies and foundations. The company pays great attention to innovation: today, BIOTECHNOS has more than 24 inventions in its portfolio.
One of the main products of BIOTECHNOS is Alflutop – original drug, solution for injection, obtained from small marine fish.
Alflutop – A chondroprotector that prevents the destruction of macromolecular structures of normal tissues, stimulates the processes of restoration of articular cartilage, and has a pronounced analgesic and anti-inflammatory effect.
To ensure proper product quality, BIOTEHNOS operates an Independent Medicines Control Laboratory, accredited at the European Union level.
Since 2005, the BIOTEHNOS quality system has been certified according to the GMP (Good Manufacturing Practice) standard and complies with the provisions of Directive EU/2003/94/CE.
In December 2008, the Environmental Management System Certificate was obtained in accordance with SR EN ISO 140001:2005. Currently, a risk management system has been implemented in BIOTEHNOS.
The activities of BIOTEHNOS specialists are highly appreciated abroad - their inventions and products have repeatedly received high awards at international invention and innovation salons. In 2015, the company received the nomination "Strongest in Romania" for fulfilling its obligations to state structures, suppliers, customers, patients, partner banks and employees.